Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Optimi Health Corp (OP:OPTHF)

0.2402 -0.0048 (-1.96%)

Streaming Delayed Price Updated: 2:07 PM EST, Dec 5, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	14,120
Open	0.2450
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.2450
Today's Range	0.2402 - 0.2450
52wk Range	0.1000 - 0.2934
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition ↗

September 16, 2024

Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pipeline with key acquisitions and partnerships.

Via Benzinga

New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia ↗

June 05, 2024

Canada Magic Mushrooms and MDMA market is hitting new milestones as canada has licensed Optimi to export psilocybin and MDMA to Australia

Via Benzinga

Performance

YTD	+48.3%	+48.3%
1 Month	-4.0%	-4.0%
3 Month	+38.1%	+38.1%
6 Month	+101.8%	+101.8%
1 Year	+60.1%	+60.1%

More News

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More ↗

April 17, 2024

Via Benzinga

Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More ↗

April 17, 2024

Via Benzinga

Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute ↗

April 09, 2024

Via Benzinga

Two Top Biotechs Forge MDMA Supply Deals For Clinical Research ↗

March 26, 2024

Via Benzinga

Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review ↗

March 16, 2024

Via Benzinga

Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More ↗

March 01, 2024

Via Benzinga

Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More ↗

January 26, 2024

Via Benzinga

Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More ↗

January 08, 2024

Via Benzinga

Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More ↗

September 11, 2023

Via Benzinga

Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing ↗

September 08, 2023

Via Benzinga

Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More ↗

August 14, 2023

Via Benzinga

Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player ↗

August 01, 2023

Via Benzinga

MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University ↗

June 20, 2023

Via Benzinga

Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More ↗

May 23, 2023

Via Benzinga

The Psychedelic Mushrooms Market; Between Legitimate Harvesting And Illegal Retail Sales ↗

May 17, 2023

Via Benzinga

Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More ↗

May 15, 2023

Via Benzinga

Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal ↗

May 11, 2023

Via Benzinga

What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry ↗

April 03, 2023

Via Benzinga

Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More ↗

March 07, 2023

Via Benzinga

Australia Receives First Batch Of Clinical-Grade Psilocybin From Mindset Pharma And PharmAla ↗

March 06, 2023

Via Benzinga

Latest Psychedelics Deals: Optimi Supplies Australia, Awakn Partners Licensing In California ↗

March 02, 2023

Via Benzinga

Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More ↗

February 13, 2023

Via Benzinga

How Do Psilocybin And MDMA Work Together? This Proposed Experiential Study Is Set To Find Out ↗

February 09, 2023

Via Benzinga

Frequently Asked Questions

Is Optimi Health Corp publicly traded?

Yes, Optimi Health Corp is publicly traded.

What exchange does Optimi Health Corp trade on?

Optimi Health Corp trades on the OTC Traded

What is the ticker symbol for Optimi Health Corp?

The ticker symbol for Optimi Health Corp is OPTHF on the OTC Traded

What is the current price of Optimi Health Corp?

The current price of Optimi Health Corp is 0.2402

When was Optimi Health Corp last traded?

The last trade of Optimi Health Corp was at 12/05/25 02:07 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.